Advertisement

Topics

Obalon Therapeutics, Inc. Company Profile

19:32 EST 9th December 2018 | BioPortfolio

Obalon is a private medical technology company based in San Diego, California focused on developing innovative, high-quality gastric balloon technology for weight loss therapy. www.obalon.com.


News Articles [714 Associated News Articles listed on BioPortfolio]

FDA OKs Obalon Therapeutics' automated inflation system

The FDA has approved Obalon Therapeutics' premarket approval supplement application for the Obalon Touch Inflation System, an -More- 

FDA Grants PMA-S Approval for Obalon Touch Inflation System

Obalon Therapeutics (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obes...

Obalon closes private placement at $10M

Obalon Therapeutics has closed a private placement of 5.5 million shares of common stock, raising $10 million in aggregate gr -More- 

PIPE grosses $10mm for Obalon

Obalon Therapeutics Inc. (devices for weight loss) grossed $10mm in a private placement of 5.5mm common shares at $1.82 (a 3% premium) to institutional investors, company management and board members,...

Obalon Therapeutics to Raise $10 Million in Private Placement

SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...

Obalon Therapeutics Announces Closing of $10 Million Private Placement

SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled ...

Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing

SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...

Private placement could pull in $10M for Obalon

A private placement deal involving 5.5 million shares has been reached by San Diego-based weight loss device maker Obalon The -More- 

PubMed Articles [457 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [166 Associated Clinical Trials listed on BioPortfolio]

Obalon US Commercial Registry

Retrospective study of the data reported in the Obalon US Commercial Registry

Obalon Post-Approval Study

The Obalon Balloon System - Post-Approval Study is a prospective, observational, and multi-center study.

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1282 Associated Companies listed on BioPortfolio]

Obalon Therapeutics, Inc.

Obalon is a private medical technology company based in San Diego, California focused on developing innovative, high-quality gastric balloon technology for weight loss therapy. ww...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "Obalon Therapeutics, Inc." on BioPortfolio

We have published hundreds of Obalon Therapeutics, Inc. news stories on BioPortfolio along with dozens of Obalon Therapeutics, Inc. Clinical Trials and PubMed Articles about Obalon Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Obalon Therapeutics, Inc. Companies in our database. You can also find out about relevant Obalon Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record